Revised transaction expands NexTel’s acquisition from JumpstartRx and NuevistraMed to Island 40 Group’s broader growth platform, adding health services, pharmaceutical access, lab testing, institutional partnerships, and diversified revenue channels

修订后的交易将 NexTel 对 JumpstartRx 和 NuevistraMed 的收购扩展至 Island 40 Group 更广泛的增长平台，新增医疗服务、药品可及性、实验室检测、机构合作伙伴关系以及多元化的收入渠道

ORLANDO, Fla., July 22, 2026 (GLOBE NEWSWIRE) -- NexTel Medical Corp. (f/k/a Exousia Pro, Inc.) (OTCID: MAJI), a clinical-stage biotechnology company focused on proprietary exosome-based delivery systems, today announced that it has amended its previously announced acquisition of JumpstartRx and NuevistraMed to include the acquisition of Island 40 Group, the parent company of JumpstartRx and NuevistraMed, and its full subsidiary platform..

佛罗里达州奥兰多，2026年7月22日（环球电讯社）——专注于专有外泌体递送系统的临床阶段生物技术公司NexTel Medical Corp.（前身为Exousia Pro, Inc.）（OTCID: MAJI）今日宣布，已对其此前宣布的收购JumpstartRx和NuevistraMed的交易进行修订，将收购范围扩展至JumpstartRx和NuevistraMed的母公司Island 40 Group及其完整子公司平台。

The revised transaction significantly expands the scope of the original acquisition by bringing NexTel a broader portfolio of health, wellness, pharmaceutical, institutional, and revenue-generation assets designed to accelerate commercial growth across multiple high-opportunity markets.

修订后的交易通过为 NexTel 带来更广泛的健康、 wellness、制药、机构及创收资产组合，显著扩大了原收购范围，旨在加速其在多个高机会市场的商业增长。

Island 40 Group is a relationship-driven growth platform built to turn capital, strategic partnerships, market access, and targeted distribution channels into measurable revenue. Through its subsidiary ecosystem, Island 40 Group works across healthcare, sports, group and employee wellness, hospitals and health systems, colleges and universities, employer groups, race teams and racing organizations, and other large targeted demographic networks..

Island 40 Group 是一个以关系驱动的增长平台，旨在将资本、战略合作伙伴关系、市场准入和定向分销渠道转化为可衡量的收入。通过其子公司生态系统，Island 40 Group 的业务涵盖医疗保健、体育、团体与员工健康、医院与健康系统、学院与大学、雇主群体、赛车团队与赛车组织，以及其他大型目标人群网络。

The acquisition is expected to strengthen NexTel’s ability to offer expanded health services, including lab testing, pharmaceutical services, personalized wellness solutions, provider support, direct-to-consumer health platforms, institutional revenue programs, and related clinical access opportunities to NexTel’s existing network of patients and prescribers, while also leveraging Island 40 Group’s broader reach.

此次收购预计将增强 NexTel 提供扩展健康服务的能力，包括实验室检测、药学服务、个性化健康解决方案、提供者支持、直接面向消费者的健康平台、机构收入计划以及相关的临床接入机会，服务于 NexTel 现有的患者和处方者网络，同时利用 Island 40 Group 更广泛的覆盖范围。

Island 40 Group currently works with more than 300,000 patients per month across its platform and affiliated channels..

Island 40 Group 目前每月通过其平台及关联渠道服务超过30万名患者。

Under the revised transaction terms, NexTel will acquire Island 40 Group and its full portfolio for total consideration of $12.75 million, consisting of $3.5 million in cash and $9.25 million in preferred stock.

根据修订后的交易条款，NexTel将以1275万美元的总对价收购Island 40 Group及其全部产品组合，其中包括350万美元现金和925万美元优先股。

“The amended transaction creates a much stronger opportunity for both Island 40 Group and NexTel because it brings the full platform under one unified governance structure, rather than separating individual assets that are more powerful when connected,” said Casey Barksdale, Founder of Island 40 Group.

“修订后的交易为Island 40集团和NexTel创造了更强大的机会，因为它将整个平台置于统一的治理结构之下，而不是将那些在连接时更具威力的单个资产分离开来。” Island 40集团创始人Casey Barksdale表示。

“Island 40 was built around relationships, market access, and revenue creation, while NexTel brings a public company platform, scientific pipeline, and broader healthcare commercialization opportunity. Together, we can pool resources, connect networks, align leadership, and move faster across health services, pharmaceutical access, lab testing, wellness programs, and institutional partnerships.

“Island 40 的构建围绕关系网络、市场准入和收入创造，而 NexTel 则带来了上市公司平台、科学研发管线以及更广阔的医疗健康商业化机遇。携手合作，我们可以整合资源、联通网络、协调领导层，并在医疗服务、药品准入、实验室检测、健康计划以及机构合作伙伴关系等领域加速推进。”

This structure gives us a clearer path to scale the entire platform, create more value for patients and providers, and build a more diversified growth engine for shareholders.”.

“这一架构为我们提供了更清晰的路径，以推动整个平台的规模化发展，为患者和医疗服务提供者创造更多价值，并为股东构建更加多元化的增长引擎。”

Island 40 Group’s subsidiary platform includes JumpstartRx, a direct-to-consumer online health and wellness platform; NuevistraMed, a pharmaceutical distribution and clinic support platform for licensed medical providers; Mascot Alliance, a partnership and revenue-generation platform serving colleges and universities, employers, healthcare organizations, and other sports properties; ParkedIt Alliance, a motorsports-focused business acceleration platform; Parked It Health, a health and wellness benefits platform serving drivers, crews, fans, and families; and VLO Flow Energy, a modern energy beverage brand built around paraxanthine-powered focus..

Island 40 Group的旗下平台包括：JumpstartRx，一个直接面向消费者的在线健康与 wellness 平台；NuevistraMed，为持牌医疗提供者提供药品分销和诊所支持的平台；Mascot Alliance，服务于高校、雇主、医疗机构及其他体育资产的合作与创收平台；ParkedIt Alliance，专注于赛车运动的商业加速平台；Parked It Health，为车手、车队成员、车迷及家庭提供健康与 wellness 福利的平台；以及VLO Flow Energy，一个以对羟基苯乙胺驱动的专注力为核心打造的现代能量饮料品牌。

“NexTel believes the amended acquisition better aligns with its long-term commercial strategy,”

“NexTel认为，修订后的收购方案更符合其长期商业战略。”

Matt Dwyer, President of NexTel Medical Corp

马特·德怀尔，NexTel医疗公司总裁

. “By adding not only direct healthcare and pharmaceutical channels, but also the broader relationship infrastructure needed to introduce new products, expand market access, and create diversified revenue opportunities across healthcare, wellness, institutional partnerships, and consumer-facing platforms.”.

“通过不仅增加直接的医疗保健和药品渠道，还构建更广泛的关系基础设施，以引入新产品、扩大市场准入，并在医疗保健、健康养生、机构合作以及面向消费者的平台等领域创造多元化的收入机会。”

Don't miss an insider look into

不要错过深入了解内部视角的机会

Island 40

40号岛

. Tune in to

收听

Buffalo Fireside Chats

布法罗炉边谈话

(@buffalofireside) on

(@buffalofireside) 在

Monday, July 27, 2026, at 4:00 PM EST

2026年7月27日，星期一，下午4:00（东部标准时间）

, where Casey will present an in-depth visual breakdown of our progress and key operational moving parts.

，届时凯西将深入展示我们进展的可视化分解以及关键运营环节。

The final closing of the revised transaction remains subject to customary closing conditions, including completion of required financial review, documentation, and other due diligence matters.

修订后交易的最终交割仍须满足惯常的交割条件，包括完成所需的财务审查、文件准备及其他尽职调查事项。

About Island 40 Group

关于 Island 40 集团

Island 40 Group is a relationship-driven growth platform built to help promising companies move from potential to performance. Through strategic access, trusted partnerships, hands-on business acceleration, and targeted distribution opportunities, Island 40 Group helps its subsidiary companies open new markets, create revenue opportunities, and build long-term enterprise value across healthcare, sports, group and employee wellness, motorsports, consumer products, and community-focused business solutions..

Island 40 Group 是一个以关系驱动的增长平台，旨在帮助有潜力的企业将潜能转化为卓越业绩。通过战略资源对接、可信赖的合作伙伴关系、务实的业务加速服务以及精准的分销机会，Island 40 Group 助力其旗下子公司开拓新市场、创造收入机遇，并在医疗健康、体育、团体与员工健康、赛车运动、消费品以及社区导向的商业解决方案等领域构建长期的企业价值。

SAFE HARBOR

安全港

Forward-looking statements in this release are made under the 'safe harbor' provision of the Private Securities Litigation Reform Act of 1995. NexTel Medical Corp's forward-looking statements do not guarantee future performance. This news release includes forward-looking statements concerning the parties' future level of business.

本新闻稿中的前瞻性陈述是根据1995年《私人证券诉讼改革法》的“安全港”条款作出的。NexTel Medical Corp的前瞻性陈述不保证未来业绩。本新闻稿包含有关各方未来业务水平的前瞻性陈述。

These statements are necessarily subject to risk and uncertainty. Actual results could differ materially from those projected in these forward-looking statements due to certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of NexTel Medical Corp., and no assurance can be given that such results will be achieved.

这些陈述必然受到风险和不确定性的影响。由于某些风险因素可能导致实际结果与预估结果产生重大差异，实际结果可能与这些前瞻性陈述中预测的结果存在重大差异。管理层提醒，所有关于未来经营业绩的陈述均必然受到风险、不确定性以及可能超出 NexTel Medical Corp. 控制范围的事件的影响，无法保证此类结果必将实现。

Potential risks and uncertainties include, but are not limited to, the ability to procure, appropriately price, retain, and complete projects and changes in products and competition..

潜在风险和不确定性包括但不限于：获取项目、合理定价、保留客户以及完成项目的能力，以及产品和竞争格局的变化。

CONTACT:

联系方式：

NexTel Medical Corp.

NexTel 医疗公司

www.nextelmedical.com

www.nextelmedical.com

X: @NexTelMedical

X：@NexTelMedical